Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Research news

Display of targets in multiple sclerosis

Tudor Toma

Author Affiliations

Genome Biology 2002, 3:spotlight-20020507-01  doi:10.1186/gb-spotlight-20020507-01

The electronic version of this article is the complete one and can be found online at:


Published:7 May 2002

© 2002 BioMed Central Ltd

Research news

Multiple sclerosis (MS) is a central nervous system autoimmune disease but molecular mechanisms underlying the disorder remain largely unknown. In May Nature Medicine, Christopher Lock and colleagues from Stanford University, California, show that microarray analysis of multiple sclerosis lesions has revealed potential new therapeutic targets (Nat Med 2002, 8:500-508).

Lock et al. compared gene expression in acute and chronic MS lesions obtained at autopsy. They observed increased transcripts of genes encoding inflammatory cytokines, particularly interleukin-6 and -17, interferon-? and associated downstream pathways.

In addition they chose two of these gene products as targets for therapy in experimental autoimmune encephalomyelitis (EAE), a murine model with similarities to MS. They observed that knocking out granulocyte colony-stimulating factor (upregulated in acute MS lesions) ameliorated EAE in the acute phase. In contrast, knocking out the immunoglobulin Fc receptor common ?chain (upregulated in chronic MS lesions) had the greatest effect on chronic disease.

"This is the first description supporting molecular differences in the two types of lesions, and provides data that could ultimately influence the choice of treatment for acute versus chronic stages of the disease" write Stephen Tompkins and Stephen Miller of Northwestern University Medical School, Chicago, Illinois, in an accompanying News & Views article.

References

  1. [http://www.nature.com/nm/] webcite

    Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, et al.: Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002, 8:500-508.

  2. [http://www.stanford.edu/ ] webcite

    Stanford University

  3. [http://www.nums.nwu.edu/] webcite

    Northwestern University, The Feinberg School of Medicine

  4. [http://www.nature.com/nm/] webcite

    Tompkins SM, Miller SD: An array of possibilities for multiple sclerosis. Nat Med 2002, 8:451-453.